Blood Pressure Control and Associated Factors among Hypertension Comorbid Type 2 Diabetic Patients in Southeast Ethiopia

Table 4

Utilization of antihypertensive and hypoglycemic agents among study participants at Bale Zone selected public hospitals, 2020 (n = 378).

Medications	Frequency	Percentage
Monotherapy (antihypertensive drug)
Nifedipine	22	5.8
Amlodipine	47	12.4
Hydrochlorothiazide	6	1.6
Atenolol	5	1.3
Enalapril	40	10.6
Dual therapy (antihypertensive drug)
Enalapril + amlodipine	113	29.9
Hydrochlorothiazide + enalapril	73	19.3
Enalapril + atenolol	32	8.5
Hydrochlorothiazide + atenolol	12	3.2
Triple therapy (antihypertensive drug)
Enalapril + amlodipine + hydrochlorothiazide	18	4.8
Furosemide + enalapril + amlodipine	10	2.7
Antidiabetic agents (drugs)
Oral hypoglycemic agent	213	56.4
Insulin	141	37.2
Insulin + oral hypoglycemic agent	24	6.4